A pharmacogenetic signature of high response to Copaxone in late-phase clinical-trial cohorts of multiple sclerosis
Journal article published in 2017 by
Colin J. Ross,
Ben Zeskind,
Fadi Towfic,
Jyoti Shankar 
,
Daphna Laifenfeld,
Mathis Thoma,
Matthew Davis,
Rebecca Kusko,
Brian Weiner ,
Volker Knappertz,
Iris Grossman,
Michael R. Hayden
,
Daphna Laifenfeld,
Mathis Thoma,
Matthew Davis,
Rebecca Kusko,
Brian Weiner ,
Volker Knappertz,
Iris Grossman,
Michael R. Hayden
This paper is made freely available by the publisher.
Full text: Download
Data provided by 